Robert Pelletier - Concepedia

Author

Robert Pelletier

Eisai (Japan)ORCID

Also Known As

Pelletier, Robert, R. D. Pelletier, R. Pelletier, R.D. Pelletier, Robert D. Pelletier, Robert Pelletier

Publications

311

Citations

H-Index

Concepts

All Affiliations

Eisai (Japan)Eisai (United States)University of Washington

About

Robert Pelletier is an author at Eisai (Japan) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	213
2	Biochemistry	4	4	115
3	Natural Sciences	2	2	43
4	Cell Biology	2	2	61
5	Engineering	1	1	36

Robert Pelletier

Publications

263

Citations

H-Index

Page 1

	Year	Citations
Preferential inducibility of CYP1A1 and CYP1A2 by TCDD: Differential regulation in primary human hepatocytes versus transformed human cells Zhiyi Zhang, Robert Pelletier, Y. Nancy Wong, Biochemical and Biophysical Research Communications CytokineSignal TransductionHepatologySignaling PathwayHuman Cells	2006	49
Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III Yongchun Shen, Roch P. Boivin, Naoki Yoneda, Bioorganic & Medicinal Chemistry Letters InflammationCytokineAnti-inflammatoryAutoimmune DiseaseMedicine	2010	37
Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4 Z.-Y. Zhang, Belinda M. King, Robert Pelletier, Cancer Chemotherapy and Pharmacology Protein FunctionSignal TransductionBiochemistryMedicineMechanism Of Action	2008	36
Dynamics and Location of the Allosteric Midazolam Site in Cytochrome P4503A4 in Lipid Nanodiscs Michelle Redhair, John C. Hackett, Robert Pelletier, Biochemistry Molecular DockingMolecular PharmacologyCytochrome P450 3A4Drug TargetEngineering	2020	36
Discovery of a potent, metabolically stabilized resorcylic lactone as an anti-inflammatory lead Hong Du, Tomohiro Matsushima, Mark R. Spyvee, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAnti-inflammatoryBiochemistryNatural SciencesMedicine	2009	28
Design and Characterization of the First Selective and Potent Mechanism-Based Inhibitor of Cytochrome P450 4Z1 John P. Kowalski, Matthew G. McDonald, Robert Pelletier, Journal of Medicinal Chemistry	2020	22
Mechanisms of Herb-Drug Interactions Involving Cinnamon and CYP2A6: Focus on Time-Dependent Inhibition by Cinnamaldehyde and 2-Methoxycinnamaldehyde Michael J. Espiritu, Justin Chen, Jaydeep Yadav, Drug Metabolism and Disposition	2020	16
Discovery of an in vitro and in vivo potent resorcylic lactone analog of LL-Z1640-2 as anti-inflammatory lead, II Yongchun Shen, Hong Du, Makoto Kotake, Bioorganic & Medicinal Chemistry Letters InflammationMedicinal ChemistryAnti-inflammatoryBiochemistryMedicine	2010	15
Pharmacokinetic characterization of a natural product–inspired novel MEK1 inhibitor E6201 in preclinical species Vipul Kumar, Edgar Schuck, Robert Pelletier, Cancer Chemotherapy and Pharmacology Pharmaceutical ScienceMedicineAnti-cancer AgentPharmacokinetic CharacterizationDrug Development	2011	12
Application of a Substrate Cocktail Approach in the Assessment of Cytochrome P450 Induction Using Cultured Human Hepatocytes Robert Pelletier, Weidong G. Lai, Y. Nancy Wong SLAS DISCOVERY	2012	12

Page 1